Berbice Capital Management’s AbbVie ABBV Stock Holding History

Berbice Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,815	Closed	-$1.05M	–	88
2026 Q1	$1.05M	Hold	4,815	–	–	0.69%	28
2025 Q4	$1.1M	Hold	4,815	–	–	0.66%	23
2025 Q3	$1.11M	Buy	4,815 +15	+0.3%	+$3.06K	0.69%	21
2025 Q2	$891K	Buy	4,800 +60	+1%	+$11.2K	0.62%	22
2025 Q1	$993K	Sell	4,740 -825	-15%	-$160K	0.86%	21
2024 Q4	$989K	Buy	+5,565	New	+$1.02M	0.79%	22

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Berbice Capital Management's ABBV Position: Q2 2026 in Review

Berbice Capital Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 4,815 shares — an estimated $1.05M sold.

Berbice Capital Management first reported a position in ABBV in Q4 2024 and held it in 6 quarters. The position peaked at $1.11M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Berbice Capital Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Berbice Capital Management sold 4,815 AbbVie shares in Q2 2026, an estimated $1.05M.
Berbice Capital Management first reported a position in AbbVie in Q4 2024 and held it in 6 quarters.
Berbice Capital Management's AbbVie position peaked at $1.11M in Q3 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Berbice Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.